已发表论文

环丙酚与丙泊酚用于妇科日间手术全身麻醉的比较:一项前瞻性、随机、双盲、非劣效性试验

 

Authors Zhang S , Dong G, Shi X , Xiao H , Nie P, Ji F

Received 9 May 2025

Accepted for publication 13 August 2025

Published 19 August 2025 Volume 2025:19 Pages 7151—7159

DOI https://doi.org/10.2147/DDDT.S539028

Checked for plagiarism Yes

Review by Single anonymous peer review

Peer reviewer comments 3

Editor who approved publication: Dr Tuo Deng

Shuwen Zhang,1 Guimin Dong,1 Xinyuan Shi,2 Hongyi Xiao,1 Peihe Nie,1,* Fanceng Ji1,* 

1Department of Anesthesiology, Weifang People’s Hospital, Weifang, People’s Republic of China; 2School of Anaesthesiology, Shandong Second Medical University, Weifang, People’s Republic of China

*These authors contributed equally to this work

Correspondence: Peihe Nie, Department of Anesthesiology, Weifang People’s Hospital, Weifang, Shandong, 261041, People’s Republic of China, Email peihenie@126.com Fanceng Ji, Department of Anesthesiology, Weifang People’s Hospital, Weifang, Shandong, 261041, People’s Republic of China, Email jifanceng@163.com

Purpose: To compare the safety and efficacy of ciprofol and propofol in general anesthesia for gynecological day surgery.
Patients and Methods: A total of 196 patients undergoing gynecological day surgery under general anesthesia were randomly divided into ciprofol and propofol group. All patients received total intravenous anesthesia. Anesthesia induction in the ciprofol group: ciprofol 0.5 mg/kg was given intravenously within 1 minute, alfentanil 20 μg/kg was given intravenously within 30 seconds, mivacurium 0.2 mg/kg was given intravenously within 30 seconds, and anesthesia maintenance: ciprofol 1.25 mg/kg/h combined with alfentanil 40 μg/kg/h was given intravenously. Anesthesia induction in the propofol group, propofol 2 mg/kg was administered intravenously within 1 min, alfentanil 20μg/kg was given intravenously within 30s, mivacurium 0.2 mg/kg was administered intravenously within 30s, and anesthesia maintenance: propofol 5 mg/kg/h combined with alfentanil 40 μg/kg/h was administered intravenously. The primary outcome was the success rate of anesthesia (defined as the number of additional study drugs administered ≤ 2 times during anesthesia induction and ≤ 2 times within 10 min during anesthesia maintenance). The secondary outcomes included time to loss of consciousness, hemodynamic changes, depth of anesthesia at different time points, additional narcotic drugs during anesthesia, use of vasoactive agents, awakening time, and incidence of adverse reactions.
Results: The success rate of anesthesia in both groups was 100%. There was no difference in the time of consciousness disappearance between the two groups during induction (81.95 vs 79.54s). Compared with the propofol group, the hemodynamics in the ciprofol group were more stable, the depth of anesthesia was better, the number of additional medications was significantly reduced, and the incidence of postoperative adverse reactions was significantly reduced. However, the awakening time of the ciprofol group was significantly longer than that of the propofol group (7.57 vs 5.52 min).
Conclusion: Ciprofol demonstrated non-inferior efficacy to propofol for gynecological day surgery anesthesia, while offering superior hemodynamic stability and reduced adverse effects.

Keywords: ciprofol, day surgery, general anaesthesia, propofol